Tonmya is the only cyclobenzaprine product approved for Tonmya. It is a first-in-class, non-opioid analgesic for fibromyalgia that is designed to be taken once a day at bedtime and its unique sublingual formulation is designed for rapid absorption into the bloodstream.| MedicalResearch.com | FDA Approves Tonmya: First-in-Class, Non-Opioid Analges...
We want readers to recognize that these recurrent pain episodes represent a serious complication for patients. Our study highlights that timely administration of opioids is not only humane, but also evidence-based in preventing hospitalizations, reducing costs, and promoting equity.| MedicalResearch.com | Top Innovations in 2025 That Help Patients and Professi...